Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy

被引：67
作者：
Giampieri, Riccardo [1 ]
Maccaroni, Elena [1 ]
Mandolesi, Alessandra [2 ]
Del Prete, Michela [1 ]
Andrikou, Kalliopi [1 ]
Faloppi, Luca [1 ]
Bittoni, Alessandro [1 ]
Bianconi, Maristella [1 ]
Scarpelli, Marina [2 ]
Bracci, Raffaella [1 ]
Scartozzi, Mario [3 ]
Cascinu, Stefano [1 ]
机构：
[1] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti, Dept Med Oncol, Ancona, Italy
[2] Univ Politecn Marche, Dept Pathol, Ancona, Italy
[3] Univ Cagliari, Dept Med Oncol, Cagliari, Italy
来源：
GASTRIC CANCER | 2017年 / 20卷 / 01期
关键词：
Gastric cancer; Mismatch repair; Microsatellite instability; Chemotherapy; Prognosis; TUMOR MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; EXPRESSION; EFFICACY; BENEFIT;
D O I：
10.1007/s10120-016-0594-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background The microsatellite-instable gastric cancer subtype, because of its supposed high antigenic potential, is a promising candidate for immunotherapy. We analyzed if the presence of a defective mismatch repair (MMR) system is associated with other markers of immune response and their relationship with outcome in advanced gastric cancer patients. We analyzed the relationship between clinical outcome and MMR status, the presence of tumor-infiltrating lymphocytes (TIL), lymphocytosis, and neutrophil-to-lymphocyte ratio (NLR) in metastatic gastric cancer patients treated with a chemotherapy doublet in the first-line setting. Other stratification factors were sex, age, Eastern Cooperative Oncology Group performance status, adjuvant/neoadjuvant chemotherapy, metastatic sites, and histotype. One hundred three patients were eligible for analysis. Defective MMR was found in 15 patients (14 %), TILs were found in 18 patients (17 %), lymphocytosis was found in 24 patients (23 %), and high NLR was found in 75 patients (72 %). Significant correlations were found between defective MMR and TIL positivity (p = 0.0004), between defective MMR and lymphocytosis (p = 0.0062), between defective MMR and low NLR (p = 0.000069), and between TIL positivity and lymphocytosis (p = 0.000147). All factors had a statistically significant impact on overall survival, although on multivariate analysis only defective MMR (p = 0.0001) and TIL positivity (p = 0.0192) maintained their independent prognostic role. Similar results were observed for progression-free survival, with defective MMR (p = 0.0001) and TIL positivity (p = 0.0195) maintaining their prognostic role on multivariate analysis. Our analysis confirms the favorable prognosis of metastatic gastric cancer patients with a defective MMR system and suggests that expression of TILs might also be linked to better outcome. Because of the correlation between defective MMR status and measures of immune system activity, this group of patients would be the best candidates for novel immunotherapy-based therapies.
引用
收藏
页码：156 / 163
页数：8
相关论文
共 18 条
[1]  
An CH, 2005, CLIN CANCER RES, V11, P656
[2]  
Bang YJ, 2010, LANCET, V376, P1302
[3]   Comprehensive molecular characterization of gastric adenocarcinoma [J].
Bass, Adam J. ;
Thorsson, Vesteinn ;
Shmulevich, Ilya ;
Reynolds, Sheila M. ;
Miller, Michael ;
Bernard, Brady ;
Hinoue, Toshinori ;
Laird, Peter W. ;
Curtis, Christina ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Weinhold, Nils ;
Keiser, David P. ;
Bowlby, Reanne ;
Sipahimalani, Payal ;
Cherniack, Andrew D. ;
Getz, Gad ;
Liu, Yingchun ;
Noble, Michael S. ;
Pedamallu, Chandra ;
Sougnez, Carrie ;
Taylor-Weiner, Amaro ;
Akbani, Rehan ;
Lee, Ju-Seog ;
Liu, Wenbin ;
Mills, Gordon B. ;
Yang, Da ;
Zhang, Wei ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Gulley, Margaret ;
Piazuelo, M. Blanca ;
Schneider, Barbara G. ;
Kim, Jihun ;
Boussioutas, Alex ;
Sheth, Margi ;
Demchok, John A. ;
Rabkin, Charles S. ;
Willis, Joseph E. ;
Ng, Sam ;
Garman, Katherine ;
Beer, David G. ;
Pennathur, Arjun ;
Raphael, Benjamin J. ;
Wu, Hsin-Ta ;
Odze, Robert ;
Kim, Hark K. ;
Bowen, Jay .
NATURE, 2014, 513 (7517) :202-209
[4]   Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[5]   Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis [J].
Des Guetz, Gaetan ;
Schischmanoff, Olivier ;
Nicolas, Patrick ;
Perret, Gerard-Yves ;
Morere, Jean-Francois ;
Uzzan, Bernard .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) :1890-1896
[6]   Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial [J].
Fuchs, Charles S. ;
Tomasek, Jiri ;
Yong, Cho Jae ;
Dumitru, Filip ;
Passalacqua, Rodolfo ;
Goswami, Chanchal ;
Safran, Howard ;
dos Santos, Lucas Vieira ;
Aprile, Giuseppe ;
Ferry, David R. ;
Melichar, Bohuslav ;
Tehfe, Mustapha ;
Topuzov, Eldar ;
Zalcberg, John Raymond ;
Chau, Ian ;
Campbell, William ;
Sivanandan, Choondal ;
Pikiel, Joanna ;
Koshiji, Minori ;
Hsu, Yanzhi ;
Liepa, Astra M. ;
Gao, Ling ;
Schwartz, Jonathan D. ;
Tabernero, Josep .
LANCET, 2014, 383 (9911) :31-39
[7]   Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer [J].
Gryfe, R ;
Kim, H ;
Hsieh, ETK ;
Aronson, MD ;
Holowaty, EJ ;
Bull, SB ;
Redston, M ;
Gallinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02) :69-77
[8]   Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer [J].
Hou, Jingying ;
Yu, Zhong ;
Xiang, Rengyun ;
Li, Chuqiang ;
Wang, Lin ;
Chen, Shufen ;
Li, Qingyun ;
Chen, Mei ;
Wang, Linyun .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 96 (03) :284-291
[9]   Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis [J].
Huang, Yong ;
Liao, Huaiwei ;
Zhang, Yong ;
Yuan, Rongfa ;
Wang, Fengmei ;
Gao, Yingtang ;
Wang, Peng ;
Du, Zhi .
PLOS ONE, 2014, 9 (05)
[10]   The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses [J].
Kim, Soo Young ;
Choi, Yoon Young ;
Shin, Hyun Beak ;
Jo, Ara ;
Choi, Hyeji ;
Seo, Sang Hyuk ;
Bang, Hui-Jae ;
Cheong, Jae-Ho ;
Hyung, Woo Jin ;
Noh, Sung Hoon ;
An, Ji Yeong .
INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (04) :819-825
12